Skip to main content
TRDA logo

TRDA

Entrada Therapeutics Inc

$4.34

6.55%

Trade Ideas Performance

Latest Closed Trade Idea

$4.34

6.55%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

1

Social

20

About

Events of Entrada Therapeutics Inc (TRDA)

In the past six months, Entrada Therapeutics' stock declined by 9.12% between October 2025 and October 2026. On November 6, 2026, the stock traded down after the company reported its third-quarter 2026 financial results, beating EPS estimates but missing revenue estimates. Insider selling activity occurred in August and September 2026 by 5Am Ventures V. L.P. and MPM Bioventures 2018 L.P. Analyst ratings varied, with Weiss Ratings and Wall Street Zen downgrading the stock, while UBS Group and HC Wainwright reiterated 'neutral' ratings, and Roth Capital reissued a 'buy' rating with an $11.00 target price. On July 22, 2026, the stock slid 3.33% due to sector volatility and a reassessment of near-term catalysts. The company's cash, cash equivalents, and marketable securities decreased from $295.7 million at year-end 2025 to $193.0 million by September 30, 2026, primarily to fund operations.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)